BW-50218

· Shanghai Argo Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BW-50218, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of BW-50218 in Healthy Participants [Phase 1]